Device
CPM
CPM is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
25%
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
withdrawn125%
completed250%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingnot_applicable
Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures
NCT04389749
withdrawnphase_2
Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis
NCT04790487
completednot_applicable
Study Comparing GAP-Flex to CPM Therapy in Treatment of TKR
NCT02670499
completednot_applicable
Early Mobilization of Knee Joint After ACL Surgery. Continuous Passive Motion Versus Manual Passive Mobilization
NCT02748759
Clinical Trials (4)
Showing 4 of 4 trials
NCT04389749Not Applicable
Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures
NCT04790487Phase 2
Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis
NCT02670499Not Applicable
Study Comparing GAP-Flex to CPM Therapy in Treatment of TKR
NCT02748759Not Applicable
Early Mobilization of Knee Joint After ACL Surgery. Continuous Passive Motion Versus Manual Passive Mobilization
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4